Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability
Raunak Shrestha,
M Llaurado Fernandez,
A Dawson,
J Hoenisch,
S Volik,
Y Lin,
S Anderson,
H Kim,
A Haegert,
S Colborne,
N Wong,
B McConeghy,
RH Bell,
S Brahmbhatt,
C Lee,
GE DiMattia,
S Le Bihan,
GB Morin,
CC Collins,
MS Carey Jan 14, 2021
